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Abstract
Interferon b (IFNb) is an antiviral cytokine secreted in response to pathogenic exposure that creates a restrictive intracellular
environment through the action of downstream interferon-stimulated genes (ISG). The objective of this study was to
examine the expression of IFNb and ISG in both human uterine epithelial cells (UEC) and the ECC-1 uterine epithelial cell line
and determine if expression changes with TLR stimulation and hormone exposure. Stimulation of primary uterine epithelial
cells and ECC-1 cells with the TLR3 agonist poly (I:C) induced the mRNA expression of IFNb, MxA, OAS2 and PKR. Other TLR
agonists including imiquimod and CpG had no effect on either IFNb or ISG expression. In contrast to ECC-1 cell responses
which were slower, maximal IFNb upregulation in UEC occurred 3 hours post-stimulation and preceded the ISG response
which peaked approximately 12 hours after poly (I:C) exposure. Unexpectedly, estradiol, either alone or prior to treatment
with poly (I:C), had no effect on IFNb or ISG expression. Blockade of the IFN receptor abrogated the upregulation of MxA,
OAS2 and PKR. Furthermore, neutralizing antibodies against IFNb partially inhibited the upregulation of all three ISG.
Estradiol, directly and in the presence of poly (I:C) had no effect on IFNb and ISG expression. These results indicate that
uterine epithelial cells are important sentinels of the innate immune system and demonstrate that uterine epithelial cells are
capable of mounting a rapid IFN-mediated antiviral response that is independent of estradiol and is therefore potentially
sustained throughout the menstrual cycle to aid in the defense of the uterus against potential pathogens.
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Introduction
The female reproductive tract (FRT) is a unique mucosal site
that must reconcile two competing functions: host defense versus
reproduction. It is the primary site of infection by sexually
transmitted diseases (STDs) including Herpes Simplex Virus
(HSV), Human Immunodeficiency Virus (HIV), Neisseria gonorrhoeae
and Chlamydia trachomatis, which cause morbidity and mortality in
large numbers of women. The innate immune response in the
FRT is a key component of host defense against these incoming
pathogens about which much still remains to be elucidated.
Epithelial cells are essential for mucosal defense providing a
physical and structural barrier against pathogen entry into the
body. They are the first cells exposed to invading pathogens and
thus, their responses could determine whether an infection occurs.
Human uterine epithelial cells (UEC) express a full complement of
pattern recognition receptors (PRR) including Toll-like receptors
(TLR) 1–9, RIG-like receptors (RLR) and NOD-like receptors
(NLR) [1,2] that recognize unique and conserved pathogen-
associated molecular patterns (PAMPs) allowing them to detect a
plethora of infectious agents. TLRs 1, 2, 4, 5 and 6 recognize
bacterial and fungal PAMPs [3]. TLR3 recognizes viral double-
stranded RNA (dsRNA) while TLR7 and 8 recognize imiquidi-
zalones such as imiquimod (IQ) and resiquimod as well as single-
stranded RNA (ssRNA) [3]. TLR9 binds to unmethylated CpG
DNA which is relatively rare in the vertebrate genome [3]. PAMP
binding to a TLR activates multiple signaling pathways that allow
a cell to generate a protective response. In previous studies we
have demonstrated that UEC respond to bacterial exposure by
secreting a panel of proinflammatory cytokines [1,4].
Type I interferons (IFNs) are a family of cytokines that can
rapidly induce a protective antiviral response and create a
restrictive environment for pathogen survival [5]. Several subtypes
of Type I IFN exist in humans including 13 isoforms of IFNa and
single forms of IFNb, IFNk, IFNv and IFNe [6]. Type I IFNs are
secreted into the external environment and signal in an autocrine
and paracrine loop through a heterodimeric receptor complex
consisting of IFN receptor 1 and IFN receptor 2 (IFNAR1 & 2)
that activate a conserved JAK/STAT signaling pathway leading to
the upregulation of hundreds of interferon-stimulated genes (ISG)
[7]. ISG involved in inhibiting the viral lifecycle include
Myxovirus A (MxA), 29-59 Oligoadenylate Synthetase (OAS) and
Protein Kinase R (PKR). MxA, a high molecular weight
cytoplasmic GTPase, is believed to exert its antiviral function by
binding viral nucleocapsid proteins, forming aggregates and thus
preventing mature virion formation and release [8]. OAS exists as
3 isoforms (OAS1-3) and catalyses the conversion of adenosine
triphosphate (ATP) into long chains of 29-59 linked oligoadenylates
[9,10]. These molecules activate the endogenous ribonuclease,
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cytoplasm in monomeric form. Upon activation by viral RNA, it
dimerizes and undergoes autophosphorlyation [9,10]. In turn,
activated PKR phosphorylates eukaryotic initiation factor 2 alpha
(eIF2a) thus leading to a general suppression in protein synthesis
[11]. Together, these three ISG represent a crucial mechanism
behind Type I IFN-mediated defense – the ability to protect the
cell by simultaneously inhibiting multiple stages of the viral
lifecycle – and are capable of inhibiting a range of different viruses
including Hepatitis C virus, HIV and HSV [12,13,14].
Every cell in the premenopausal FRT exists in an environment
that is constantly exposed to varying levels of the sex hormones
estradiol and progesterone. Previously, we have shown that
estradiol regulates several aspects of the innate immune system
in the FRT. In human UEC estradiol stimulates the production of
antimicrobial compounds such as elafin and secretory leukocyte
protease inhibitor (SLPI) that are essential in restricting viral and
bacterial infections [15,16]. However, estradiol can also be
inhibitory. For example, it represses the TLR3-induced secretion
of cytokines such as IL-6 and IL-8 in UEC [17]. Whether estradiol
directly regulates the Type I IFN pathway, and thus alters
intracellular innate immune protection has never been studied in
UEC.
We examined the Type I IFN response of UEC to a panel of
viral TLR agonists and demonstrated that UEC are exquisitely
sensitive to dsRNA stimulation which transiently (over 24 hours)
leads to a rapid intracellular antiviral response. Treatment with
other viral TLR ligands did not induce a Type I IFN response. We
examined the role of estradiol in modulating the IFN pathway and
found that hormonal treatment does not alter the response profile
of ISG in UEC. Overall, this study demonstrates the presence of a
functional Type I IFN pathway in primary polarized UEC and the
ECC-1 cell line that is responsive to the presence of dsRNA, is
unaffected by the presence of estradiol and therefore provides a
constant level of protection across the menstrual cycle.
Materials and Methods
Source of uterine tissue
Human uterine tissue was obtained immediately following
surgery from premenopausal women who had undergone
hysterectomies at Dartmouth-Hitchcock Medical Center (Leba-
non, NH). Tissues used in this study were distal to the sites of
pathology and were determined to be unaffected with disease upon
inspection by a trained pathologist. All investigations involving
human subjects were conducted according to the principles
expressed in the Declaration of Helsinki and carried out with
the approval from the Committee for the Protection of Human
Subjects (CPHS), Dartmouth Hitchcock Medical Center, and with
written informed consent obtained from the patients before
surgery.
Isolation of Uterine Epithelial Cells (UEC)
Epithelial cells were isolated as previously described [18].
Briefly, tissues were minced under sterile conditions into 1 to
2 mm fragments and subjected to enzymatic digestion using an
enzyme mixture that contained final concentrations of 3.4 mg/ml
pancreatin (Invitrogen Life Technologies, Carlsbad, CA), 0.1 mg/
ml hyaluronidase (Worthington Biochemical, Lakewood, NJ),
1.6 mg/ml collagenase (Worthington Biochemical), and 2 mg/
ml D-glucose, in 16HBSS (Invitrogen). Enzymes were chosen to
maximize digestion of the extracellular matrix while minimizing
digestion of cell surface antigens. After enzymatic digestion for
2 hours at 37uC, cells were dispersed through a 250-mm mesh
screen, washed, and resuspended in DMEM/F12 Complete
medium. Complete medium was supplemented with 20 mM
HEPES (Invitrogen), 2 mM L-glutamine (Invitrogen), 50 mg/ml
primocin (Invivogen) and 10% heat-inactivated defined Fetal
Bovine Serum (FBS) (ThermoScientific, Logan, UT).
Epithelial cell sheets were separated from stromal cells by
filtration through a 20-mm nylon mesh filter (Small Parts, Miami
Lakes, FL). Epithelial sheets were retained on the 20-mm filter,
while stromal cells passed through. Epithelial sheets were
recovered by rinsing and backwashing the filter with Complete
medium. Epithelial sheets were collected, centrifuged at 5006g for
10 min, and analyzed for cell number and viability.
UEC culture
To establish a cell culture system of polarized human UEC with
both apical and basolateral compartments, human UEC were
cultured in Falcon cell culture inserts coated with Human
Extracellular Matrix (Becton Dickinson, Franklin Lakes, NJ) in
24-well culture plates (Fisher Scientific, Pittsburgh, PA). Apical
and basolateral compartments had 300 and 850 ml of complete
medium respectively. The medium was changed every 2 days.
ECC-1 cell culture
ECC-1 cell line is a well-differentiated human UEC line that is
responsive to sex hormones [19]. To establish a culture system of
polarized human ECC-1 cells with both apical and basolateral
compartments, the human UEC line ECC-1 (originally established
by Dr Pondichery Satyaswaroop and kindly provided by George
Olt, Penn State College of Medicine, Milton S Hershey Medical
Center, PA) was cultured in uncoated Falcon cell culture inserts in
24-well culture dishes (Fisher Scientific). Apical and basolateral
compartments had 300 and 850 ml of complete medium
respectively. The medium was changed every 2 days.
PBMC culture
Peripheral blood mononuclear cells (PBMC) were isolated from
a blood cone and cultured in RPMI medium (Gibco) supplement-
ed with 20 mM HEPES, 2 mM L-glutamine, 50 mg/ml primocin
and 10% heat-inactivated defined FBS prior to TLR stimulation.
TLR agonists, Interferon Neutralization and Receptor
Blockade and Estradiol Stimulation
Polarized epithelial cells were apically stimulated with various
TLR agonists at the following concentrations unless otherwise
stated: poly (I:C) (Invitrogen,) 25 mg/ml; imiquimod (Invivogen,
San Diego, CA) 100 mM and CpG oligonucleotide (Invivogen)
1 mM.
Recombinant human IFNb (PBL Interferon Source, Piscat-
away, NJ) was used to stimulate polarized UEC or ECC-1 cells for
24 hours. IFNb neutralization experiments were conducted using
a rabbit polyclonal anti-human IFNb neutralizing antibody
(aIFNb) (R&D Systems, Minneapolis, MN). Interferon receptor
blockade experiments were conducted using a mouse monoclonal
anti-human interferon receptor 2 (IFNAR2) blocking antibody
(R&D Systems)
For all hormone experiments, 17b-estradiol (Calbiochem,
Gibbstown, NJ) was dissolved in 100% ethanol for an initial
concentration of 1610
23 M, evaporated to dryness and resus-
pended in Complete media containing charcoal dextran-stripped
FBS to a concentration of 1610
25 M. Further dilutions were
made to achieve final working concentrations of estradiol ranging
from 5610
28 Mt o5 610
212 M. As a control, an equivalent
amount of ethanol without dissolved hormone was initially
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and basolateral compartments.
In all experiments with TLR agonists, IFN blockade and
neutralization, or sex hormones, Complete medium containing
10% heat-inactivated FBS was replaced with Complete medium
supplemented with 10% heat-inactivated charcoal/dextran-treat-
ed Stripped FBS (Gemini, West Sacramento, CA).
Detection of IFNb secretion
IFNb secretion was analyzed by an enzyme-linked immunosor-
bent assay (R&D Systems). Briefly, cell culture conditioned media
was recovered and centrifuged at 500 g for 5 minutes. The
resulting supernatant was stored at 280uC until required.
Measurement of transepithelial resistance (TER) and cell
viability
As an indicator of tight junction formation of epithelial cell
monolayers, TER was periodically assessed using an EVOM
electrode and Voltohmmeter (World Precision Instruments,
Sarasota, FL). All cell cultures had TER values greater than
1000 V/insert when experiments were performed. Cell viability
was assessed using the CellTiter Cell Viability Assay (Promega,
Madison, WI) as per the manufacturer’s instructions.
TaqMan real-time RT-PCR
Total RNA was isolated from cells using TRIzol Reagent
according to the manufacturer’s recommendations (Invitrogen)
and purified on RNeasy columns (Qiagen, Valencia, CA) with on-
column DNase digestion using the RNase-Free DNase set
(Qiagen). 400 ng of total RNA was reverse-transcribed using the
iScript cDNA synthesis kit (Bio-Rad) according to the manufac-
turer’s recommendations. Relative mRNA expression levels of
genes of interest were measured using the 59 fluorogenic nuclease
assay in real-time quantitative PCR using TaqMan chemistry on
the ABI 7300 Prism real-time PCR instrument (Applied
Biosystems, Carlsbad, CA). The IFN-b, OAS2, MxA, PKR, b-
actin, progesterone receptor primer/MGB probe sets were
obtained from Applied Biosystems assays-on-demand (ID
nos. Hs00277188, Hs00942643, Hs00182073, Hs00169345,
4333762F and Hs01556702 respectively). PCR was conducted
using the following cycle parameters: 95uC, 12 min for 1 cycle
(95uC, 20 s; 60uC, 1 min), for 40 cycles. Analysis was conducted
using the sequence detection software supplied with the ABI 7300.
The software calculates the threshold cycle (Ct) for each reaction
and this was used to quantify the amount of starting template in
the reaction. The Ct values for each set of duplicate reactions were
averaged for all subsequent calculations. A difference in Ct values
(DCt) was calculated for each gene by taking the mean Ct of each
gene of interest and subtracting the mean Ct for the housekeeping
gene b-actin for each cDNA sample. Assuming that each reaction
functions at 100% PCR efficiency, a difference of one Ct
represents a 2-fold difference. Relative expression levels were
expressed as a fold-increase in mRNA expression and calculated
using the formula 2
2DDC
t.
Results
Effect of viral TLR agonists on cell viability and
transepithelial resistance
Antiviral responses evoked by TLR stimulation can sometimes
induce apoptosis as the cell seeks to limit potential sites of viral
replication [20,21,22]. We sought to determine the effect of viral
TLR stimulation on cell viability and found that TLR agonist
treatment had no effect on epithelial cell viability compared to
untreated samples (data not shown). We also investigated whether
viral TLR agonists affect barrier function of epithelial cells by
measuring changes in TER values of polarized ECC-1 cells. As
seen in Figure 1, poly (I:C) and CpG, when placed in the apical
compartment, had no effect on TER at either 12 or 24 hours,
relative to untreated controls. In contrast, IQ decreased TER by
approximately 50% after 12 hours of exposure. At 24 hours post-
exposure, in the continued presence of IQ, TER values had
partially recovered but had not yet reached pre-treatment values.
Viral TLR stimulation of uterine epithelial cells
Previously we have shown that ECC-1 cells and primary UEC
express the full complement of human TLRs and that they
respond to stimulation by upregulating proinflammatory cytokines
and antimicrobials [1,4]. However, the effect of viral TLR
stimulation on Type I IFNs and ISG has not been fully
determined. To test the hypothesis that viral TLR agonists
regulate IFNb and ISG expression, we apically treated confluent
monolayers of ECC-1 cells or primary UEC for 24 hours with
poly (I:C), IQ and CpG before recovering and analyzing cell
culture conditioned media and total cellular mRNA. The
expression of MxA, OAS2, PKR and IFNb was upregulated in
response to poly (I:C) (Figure 2a & b). In contrast, IQ and CpG
added at concentrations known to have stimulatory effects on
cytokine secretion [1,23] did not induce IFNb or ISG expression
in either ECC-1 s or UEC (Figure 2a & b, d & e). Recognizing that
one explanation for the lack of a response towards IQ and CpG
could be due to inactive ligand, we repeated the experiments in
PBMC. All three ligands upregulated MxA, OAS2 and PKR
mRNA expression (Figure 2c). Furthermore, stimulation increased
both IFNb mRNA expression (Figure 2c) and secretion (Figure 2f)
thus demonstrating that IQ and CpG were not defective and were
able to induce gene expression in a different cell type.
Poly (I:C) stimulation of uterine epithelial cells
To further elucidate the temporal response of IFNb and the
ISG, we exposed ECC-1 cells to multiple concentrations of poly
(I:C) for a range of time-points up to 24 hours. As shown in
Figure 3, no increase in ISG was observed in ECC-1 cells at 3 and
6 hours post-stimulation. Maximum ISG expression occurred after
12 hours of treatment with mRNA levels of MxA, OAS2 and
PKR increasing approximately 3-, 13- and 4-fold, respectively,
beyond that seen in untreated controls (Figure 3a–c). An increase
in IFNb expression preceded that of the ISG with a 7-fold
upregulation measured 3 hours after poly (I:C) stimulation
(Figure 3d). IFNb expression peaked at 12 hours and then
declined by 24 hours. Furthermore, poly (I:C) demonstrated
dose-dependent effects on gene expression with maximal levels
of IFNb and ISG reached with 25 mg/ml of poly (I:C) and
subsequently declining at 2.5 mg/ml and 0.25 mg/ml (Figure 3a–
d).
In parallel studies with polarized human UEC, a similar pattern
was observed. As seen in Figure 3e–h, ISG expression peaked at
12 hours post-stimulation when UEC were incubated in the
presence of poly (I:C) (25 mg/ml) placed in the apical compart-
ment. However, unlike the ECC-1 cells, ISG levels were
upregulated earlier at 6 hours post-stimulation. These studies
further demonstrated that IFNb peaked prior to the upregulation
in ISG. In contrast to ECC-1 cells whose response was more
gradual, primary UEC IFNb expression was highest at 3 hours
post-poly (I:C) exposure (mean=1600; range=53–3444), and
steadily declined towards 24 hours (mean=30; range=1.42–100).
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The Type I IFN response has not been studied extensively in the
human FRT epithelium despite it being a major site of STD
transmission. To establish that polarized uterine cells are
responsive to IFNb, ECC-1 cells were incubated with a
combination of recombinant human IFNb (10
1,1 0
2 &1 0
3 U/
ml), IFNb neutralizing antibody (aIFNb) or IFNAR2 blocking
antibody (aIFNAR2) for 24 hours prior to analysis of ISG
(Figure 4a). IFNb dose-dependently increased mRNA expression
of MxA, OAS2 and PKR. OAS2 was most sensitive to the
presence of IFNb, increasing by approximately 30 (10
1 U/ml) and
120- (10
3 U/ml) fold over unstimulated levels, while MxA went up
6 and 20-fold respectively. In contrast, PKR was the least sensitive
to IFNb, increasing maximally by 6-fold at 10
3 U/ml.
Addition of exogenous IFNb (10
3 U/ml) to UEC (Figure 4b)
also induced MxA, OAS2 and PKR. However, the difference
between the three genes was less stark with MxA and OAS2 both
increasing between 5 to 20-fold (Figure 4b) over untreated levels.
Similar to the ECC-1 cells, PKR appeared to be the least sensitive
to IFNb and was only upregulated by approximately 2 to 5-fold.
As a part of these experiments, we concurrently treated the UEC
with both poly (I:C) and the aIFNb antibody and discovered that
expression of MxA, OAS2 and PKR were inhibited by
approximately 20–40% (Figure 4c). To further elucidate the
importance of IFNb in the response to dsRNA, UEC and ECC-1
cells were pre-incubated with aIFNAR2 [24] for 1 hour and
subsequently stimulated with poly (I:C) for 24 hours. As shown in
Figure 4d, antibody pre-incubation partially abrogated the
upregulation of the three ISG in presence of poly (I:C).
Estradiol stimulation of uterine epithelial cells
Epithelial cells in the upper FRT exist in an environment that is
constantly exposed to levels of estradiol which vary with the stage
of the menstrual cycle [25]. Previous studies from our laboratory
have demonstrated that estradiol directly upregulates the produc-
tion and secretion of protective antimicrobials including human b
defensin-2 (HBD2) and SLPI, while inhibiting LPS and poly (I:C)-
induced secretion of MIF, IL-6 and IL-8 by primary UEC [16].
Recognition of the complex interactions between estradiol and
UEC immune responses led us to investigate whether estradiol
regulates IFNb or ISG mRNA expression. ECC-1 and primary
UEC were exposed to estradiol (5610
28 M) apically and
basolaterally. As seen in Figure 5, estradiol had no effect on
IFNb, MxA, OAS2 and PKR expression measured at 24 hours. In
other experiments, when estradiol was added to the culture media
for 3, 6, 12 and 48 hours (data not shown), no effects on IFNb and
ISG expression were seen in either ECC-1 or UEC. This lack of a
response was not due to a defect in estradiol signaling pathways.
Recognizing that estradiol stimulates the synthesis of progesterone
receptor (PR) [26], we measured progesterone receptor mRNA
levels and found increased expression at 24 hours in both ECC-1
and UEC (Figure 5c & d). Further, since ECC-1 and UEC TER
values are known to decrease with estradiol treatment [16], we
confirmed that hormone treatment decreased TER (data not
shown) while having no effect on either ISG and IFNb expression.
Given that estradiol levels in blood vary with stage of the
menstrual cycle, we extended these studies and carried out dose
response experiments with ECC-1 cells at concentrations ranging
from 5610
28 Mt o5 610
212 M over the same time (3–48 hr)
periods. Irrespective of the dose of estradiol used, no change in
IFNb, MxA, and OAS2 or PKR expression was detected (data not
shown).
Estradiol and Poly (I:C) co-stimulation of epithelial cells
Previous studies have shown that estradiol can regulate TLR-
induced responses in the FRT [16,17]. We therefore investigated
whether estradiol would enhance or inhibit the upregulation of
IFNb and the ISG by poly (I:C). To test this hypothesis, ECC-1
cells and primary UEC were pretreated apically and basolaterally
with estradiol (5610
28 M) for 24 hours followed by 12–24 hours
incubation with poly (I:C) during which estradiol was maintained
in the culture media. As shown in Figure 6, estradiol had no effect
on the poly (I:C)-induced upregulation in IFNb, MxA, OAS2 and
PKR mRNA in either ECC-1 cells (6a) or primary UEC (6b) after
12 hours (not shown) or 24 hours of poly (I:C) exposure.
Furthermore, estradiol did not modulate the secretion of IFNb
in either cell type (Figure 6c & d). Additional experiments with
ECC-1 cells using lower concentrations of hormone and extending
the pretreatment period to 48 hours confirmed that estradiol had
no effect on either IFNb or ISG expression (data not shown).
Discussion
These studies demonstrated that human UEC and ECC-1
upregulate IFNb in response to poly (I:C), a dsRNA viral mimic.
When added to the culture media of polarized epithelial cells,
IFNb induced expression of MxA, OAS2 and PKR – a subset of
Figure 1. Imiquimod transiently decreases transepithelial resistance in ECC-1 cells. ECC-1 cells (representative of three independent
experiments) were cultured on cell inserts until confluent and then apically stimulated with poly (I:C) (TLR3), IQ (TLR7/8) and CpG (TLR9) at the
concentrations shown above. TER measurements were taken at 12 and 24 hours post-stimulation. Results are shown as the mean +/2 SEM.
doi:10.1371/journal.pone.0035654.g001
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PLoS ONE | www.plosone.org 4 April 2012 | Volume 7 | Issue 4 | e35654Figure 2. Epithelial cells induce IFNb and ISG gene expression in response to poly (I:C). ECC-1 (n=3) (a & d), and primary human UEC
(n=3) (b & e) were cultured on cell inserts until confluent with a TER above 1000 ohms and then apically stimulated with poly (I:C) (25 mg/ml), IQ
(100 mM) and CpG (1 mM) for 24 hours. The same treatment was applied to primary human PMBC cultured in a 24-well plate (n=3) (c & f). Cell culture
conditioned media was recovered and analyzed by ELISA for IFNb secretion (d, e & f). Concurrently total cellular mRNA was isolated and analyzed for
changes in gene expression (a, b & c). mRNA is expressed as a fold change over untreated samples (assigned a value of 1). (ND=below detection limit
of the ELISA assay).
doi:10.1371/journal.pone.0035654.g002
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of IFNb action, either by blockade of IFNAR2 or by IFNb
neutralization, partially abrogated increases of MxA, OAS2 and
PKR in the presence of poly (I:C). The sex hormone estradiol had
no effect on IFNb or ISG expression, either alone or with poly
(I:C) stimulation. Overall, these studies indicate that ISG are
present in uterine epithelial cells and under appropriate condi-
tions, are up-regulated by IFNb independently of estradiol.
Type I IFNs are secreted in response to pathogenic stimulation
and rapidly induce an antiviral state in adjacent cells via their
ubiquitously expressed cell-surface receptor complex consisting of
IFNAR1 and 2 [5]. In turn, IFNAR signaling upregulates the
expression of hundreds of proteins, many of which have been
implicated in cellular defense from pathogen infection [5,7]. MxA,
OAS2 and PKR are three well characterized ISG whose
expression we profiled after stimulation with synthetic agonists to
TLR3, 7/8 and 9. We have demonstrated that the upregulation of
IFNb and the ISG (MxA, OAS2 and PKR) in UEC is specific to
poly (I:C), with no response to IQ or CpG at known stimulatory
concentrations [2,23]. Why TLR7/8 and TLR9 stimulation did
not induce an IFN response in UEC is unknown. All three
receptors are expressed and functional within UEC and ECC-1
cells [4,27]. For example, TLR7/8 stimulation by loxoribine
inhibits basolateral MCP-1 secretion in ECC-1 cells [1]. Primary
cultured uterine cells upregulate the expression of CXCL8 in
response to TLR7/8 and 9 agonists at similar doses to ours [2].
Figure 3. IFNb transcription precedes the upregulation in ISG expression, with maximal ISG mRNA levels occurring approximately
12 hours after administration of poly (I:C). ECC-1 (n=3) (a–d) and primary human UEC (n=5) (e–h) were cultured on cell inserts and then
apically stimulated with poly (I:C) for 3, 6, 12 and 24 hours. ECC-1 cells were stimulated with 0.25, 2.5 or 25 mg/ml of poly (I:C) while UEC were
stimulated with 25 mg/ml of poly (I:C). Total cellular mRNA was recovered and analyzed for gene expression. mRNA is expressed as a fold change over
untreated samples (assigned a value of 1).
doi:10.1371/journal.pone.0035654.g003
Figure 4. Inhibition of IFNb signaling results in partial abrogation of poly (I:C)-induced ISG upregulation. (a) ECC-1 cells (n=2) were
cultured on cell inserts until confluent and subsequently stimulated with multiple doses of recombinant human IFNb (10
1,1 0
2 &1 0
3 U/ml) for
24 hours (left panel) in the presence or absence of either neutralizing antibody for IFNb (aIFNb) (middle panel) or blocking antibody against
interferon receptor 2 (aIFNAR2) (right panel). For the neutralization experiments aIFNb and IFNb were first mixed together in an eppendorf tube and
then added to both compartments for 24 hours. For the receptor blockade experiments cells were pretreated apically and basolaterally with aIFNAR2
or IgG control (not shown) for 1 hour prior to apical stimulation with poly (I:C) for a subsequent 24 hours during which aIFNAR2 was maintained in
the cell culture media. (b) Primary human UEC from two individual patients were cultured on cell inserts until confluent and then stimulated with
10
3 U/ml of recombinant IFNb for 24 hours. (c) Concurrently, the UEC were treated with poly (I:C) for 24 hours in the presence or absence of
neutralizing antibody for IFNb (aIFNb). (d) ECC-1 cells (n=3) or primary human UEC (Patient 8) (representative of 2 separate experiments) were
cultured on cell inserts until confluent. Cells were pretreated with aIFNAR2 or IgG control (not shown) for 1 hour prior to apical stimulation with poly
(I:C) for a subsequent 24 hours during which aIFNAR2 was maintained in the cell culture media. Total cellular mRNA was recovered and analyzed for
gene expression. mRNA is expressed as a fold change over untreated samples (assigned a value of 1).
doi:10.1371/journal.pone.0035654.g004
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cervical epithelial cells [28], and MIP-1a in murine vaginal
epithelial cells [29]. However, the unique sensitivity of UEC and
ECC-1 to poly (I:C) raises an intriguing question about their
potential responses to pathogens they may encounter in vivo. HIV,
for example, is recognized by TLR7 in specific subsets of immune
cells. Could the inability of uterine epithelial cells to mount an
effective Type I IFN response to TLR7/8 stimulation also imply
they are insensitive to the presence of HIV and would this allow
for increased viral transmission?
What confers epithelial sensitivity to dsRNA is unresolved but
may involve TLR3 and potentially two additional PRRs known to
recognize dsRNA: the cytosolic retinoic acid-inducible gene I
(RIG-I) and melanoma differentiation-associated gene 5 (MDA5)
which bind poly (I:C) [30]. The presence of multiple receptors
capable of recognizing dsRNA may dramatically increase cellular
sensitivity to poly (I:C). Both receptors are present in FRT
epithelial cells (Wira and Ghosh, Unpublished observation). While
the functionality of RIG-I and MDA5 in the uterine epithelium
has never been studied, in lung epithelial cells RIG-I activation by
influenza causes a Type I IFN-dependent antiviral response [31].
In contrast, TLR3 stimulation leads to a proinflammatory
response. This could explain our past results where blockade of
TLR3 signaling in UEC failed to inhibit IFNb, MxA and OAS1
but not Human Beta Defensin 2 (HBD2) or TNFa [4].
Alternatively, the upregulation in IFNb and the ISG may be
due to the cumulative effect of all three PRRs signaling in synergy
[32]. Further studies are needed to determine whether the PRRs
act individually, or in combination, to mediate the effects of poly
(I:C) on IFNb and ISG production. Overall, our past and present
findings demonstrate that uterine ECC-1 epithelial cells and UEC
recognize multiple TLR agonists but that the regulation of IFNb
and ISG expression is distinct from other induced immune
responses in that their responsiveness is confined to dsRNA.
Unexpectedly, we found that when secretions from poly (I:C)-
stimulated cells were neutralized with an IFNb-specific antibody,
ISG upregulation in UEC was only partially abrogated (30–40%).
Inadequate antibody blockade is unlikely since we used a
concentration of antibody that abrogated IFNb signaling in
ECC-1 cells and was previously shown to completely block HSV-
2-induced IFNb signaling in UEC [23]. One explanation for our
findings of a partial reduction is that, in addition to IFNb, other
Type I IFNs, such as IFNa or e, are essential for the antiviral
response in the human FRT. Recognizing that all Type I IFNs use
the same receptor complex consisting of IFNAR1 and 2 to initiate
signaling, we extended our studies and used a blocking antibody
against IFNAR2 and achieved a partial reduction in ISG
expression in the presence of poly (I:C). Given the similar levels
Figure 5. Estradiol has no effect on IFNb and ISG transcript levels. ECC-1 (n=3) (a & c) and primary human UEC (n=5) (b & d) were stimulated
apically and basolaterally by estradiol (5610
28 M) for 24 hours. mRNA was recovered and analyzed for changes in gene expression. mRNA is
expressed as a fold change over untreated samples (assigned a value of 1). Results are shown as the mean +/2 SEM.
doi:10.1371/journal.pone.0035654.g005
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results suggest that IFNb is the dominant Type I IFN expressed by
uterine epithelial cells – a feature observed in other cell types [33].
Alternatively, since we were unable to entirely block ISG
upregulation, these studies suggest the existence of other IFN
receptors capable of inducing ISG expression in epithelial cells.
Signaling via the IL28Ra and IL10Rb receptor complex by IL29
and IL28A/B has been demonstrated to upregulate MxA and
OAS2 in human hepatic and intestinal epithelial cells [34,35].
Whether these cytokines are expressed in the human endometrium
is unknown, but they have been shown to function primarily at
epithelial surfaces, induce a similar gene profile to Type I IFNs
and are upregulated in response to poly (I:C) in cell-specific
manner [36,37].
Epithelial cells are poised to respond to viral pathogens by
rapidly upregulating IFNb and subsequently, the ISG. Similar to
findings elsewhere [38], in our system this response is promptly
resolved and brought under control, and after 24 hours of poly
(I:C) exposure IFNb and ISG mRNA responses were barely
detectable. The similarity between the temporal dynamics and
mechanisms of UEC and ECC-1 responses further indicates that
ECC-1 cells are a valid model for studying the effects of viral
stimulation on the IFNb-mediated response in the upper FRT.
Despite its protective properties, uncontrolled Type I IFN
signaling is associated with increased inflammation and disease
progression [39]. The tight control of IFN signaling observed here
may be maintained via the action of several proteins including
suppressors of cytokine signaling (SOCS) 1 and 3 as seen in human
HepG2 cells and 293T cells [40,41,42].
The speed of the antiviral response probably allows uterine
epithelial cells to confer protection against viral pathogens such as
HIV and HSV that periodically enter the upper FRT after vaginal
sexual intercourse. Type I IFNs are believed to have essential roles
in restricting these pathogens [43,44]. Indeed, loss of Type I IFN
signaling is associated with increased HSV-2 acquisition in female
mice [45]. Pretreatment of immune cells with IFN inhibits HIV
replication [46], and both OAS2 and PKR are known to restrict
HIV in vitro [47,48]. In dendritic cells poly (I:C) stimulation leads
to increased secretion of Type I IFNs and subsequent upregulation
of ISG that inhibit HIV replication in infected cells [44]. The
exquisite sensitivity of uterine epithelial cells to dsRNA, a
component of the HIV genome [49], may be essential in reducing
Figure 6. Estradiol has no effect on the poly (I:C)-mediated increase in IFNb, MxA, OAS2 and PKR. ECC-1 (n=3) (a & c) and primary
human UEC (n=3) (b & d) were pretreated with estradiol (5610
28 M) for 24 hours. Following media and hormone replenishment, poly (I:C) (25 mg/
ml) was added for 12 hours after which both cell culture conditioned media and mRNA were recovered and analyzed by ELISA (c & d) and RT-PCR (a &
b) respectively. mRNA is expressed as a fold change over untreated samples (assigned a value of 1). Results are shown as the mean +/2 SEM.
ND=below the limit of detection of the ELISA assay.
doi:10.1371/journal.pone.0035654.g006
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mediated protection for the host, both HSV2 and HIV encode
viral proteins that actively subvert its ability to restrict their
replication. The HSV-2 virion host shut-off (vhs) protein inhibits
dsRNA-induced antiviral signaling in human vaginal epithelial
cells by interfering with TLR3/MDA5 recognition and suppress-
ing IFNb secretion [50]. In a similar fashion, the HIV protein
TAT induces SOCS3 expression to suppress IFNb signaling and
thus increase HIV replication in macrophages [51]. The ISG
themselves are also targets of HIV, and both PKR and OAS2 can
be subverted by the TAR element on HIV RNA and RNaseL
inhibitor respectively [52,53]. However, while the preponderance
of evidence suggests that ISG are protective for the host cell, some
studies have shown that ISG upregulation can predispose a cell to
increased infection [14]. For example, HSV-1 induces the
expression of a unique isoform of MxA that increases viral
replication in human fibroblasts [54]. Therefore, it is important to
appreciate the possibility that ISG upregulation may not always
increase protection.
Previous studies by us demonstrated that estradiol and
progesterone regulate a spectrum of uterine epithelial cell immune
functions, including tight junction formation, cytokine and
antimicrobial secretion, as well as antigen presentation [25]. For
example, estradiol increases antimicrobial (SLPI and elafin)
expression in the upper FRT at a time when other immune
parameters are suppressed to optimize conditions for successful
pregnancy [16]. The present studies build on this foundation in
several ways. Estradiol had no effect on constitutive IFNb, MxA,
OAS2 and PKR mRNA expression. These findings suggest that
Type I IFN and ISG expression in epithelial cells is insensitive to
the presence of sex hormones and thus provides a constant level of
protection across the menstrual cycle. In other studies, estradiol
upregulated mRNA levels of ISG20/HEM45 in human UP1,
MDA-L3 and MCF-7 tumor cell lines [55]. Our lack of an
estradiol-induced response is in stark contrast to other aspects of
the innate immune system in the FRT where we have
demonstrated that estradiol has a significant regulatory role
[16,56]. To the best of our knowledge, our findings are the first to
demonstrate that physiological concentrations of estradiol, which
are biologically active in our cells in that they induce the
expression of progesterone receptor (Figure 5), have no effect on
Type I IFN signaling in uterine epithelial cells.
The present studies demonstrated that pretreatment of epithelial
cells with estradiol had no effect on poly (I:C)-induced IFNb and
ISG expression. These findings are in contrast to our previously
published findings that cytokine and chemokine secretion in
response to TLR agonists are dampened when epithelial cells are
pretreated with estradiol [16]. For example, whereas estradiol had
no effect on constitutive secretion of proinflammatory cytokines
and chemokines by uterine epithelial cells, it inhibited LPS and
poly (I:C)-induced secretion of MIF, IL-6 and IL-8. Estradiol also
reversed the stimulatory effects of IL-1a on mRNA expression of
TNFa, IL-8 and NFkB [17]. Overall, the present study indicates
that the production of IFNb and ISG by UEC are selectively
unresponsive to estradiol. Further, it suggests that the presence of
IFNb and ISG in epithelial cells which line the uterine cavity have
evolved immunologically to be sensitive to viral infections
throughout the menstrual cycle to enhance the chances of
procreation. In contrast to our findings with epithelial cells,
estradiol pretreatment of human dendritic cells inhibits the
upregulation of IFNb and MxA in response to Newcastle’s
Disease Virus (NDV) [57] without affecting IFNb-induced RIG-I,
MxA, IP10 or STAT1 expression [57]. That protection against
viral infection occurs without accompanying inflammation is
essential for successful fertilization and implantation. Further
studies are needed to more fully understand the dynamic balance
that exists between innate intracellular protection and reproduc-
tive function [58].
In conclusion, we demonstrated the presence of a robust IFNb-
mediated response to poly (I:C) which is unaffected by estradiol in
both human UEC and ECC-1 cells. The lack of an estradiol effect
suggests a degree of protection that is unaffected by hormonal flux
across the menstrual cycle thus indicating the importance of
maintaining a constant level of Type I IFN-mediated innate
immune protection.
Acknowledgments
We thank all the study participants. We also thank the Department of
Pathology, the Obstetrics and Gynecology surgeons, operating room
nurses, and support personnel at Dartmouth-Hitchcock Medical Center.
We are grateful to Richard M. Rossoll, Zheng Shen and Yan Song for
technical support.
Author Contributions
Conceived and designed the experiments: MVP MG JVF CRW.
Performed the experiments: MVP. Analyzed the data: MVP. Wrote the
paper: MVP CRW.
References
1. Pioli PA, Amiel E, Schaefer TM, Connolly JE, Wira CR, et al. (2004)
Differential expression of Toll-like receptors 2 and 4 in tissues of the human
female reproductive tract. Infect Immun 72: 5799–5806.
2. Hart KM, Murphy AJ, Barrett KT, Wira CR, Guyre PM, et al. (2009)
Functional expression of pattern recognition receptors in tissues of the human
female reproductive tract. Journal of Reproductive Immunology 80: 33–40.
3. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate
immunity: update on Toll-like receptors. Nat Immunol 11: 373–384.
4. Schaefer TM, Fahey JV, Wright JA, Wira CR (2005) Innate Immunity in the
Human Female Reproductive Tract: Antiviral Response of Uterine Epithelial
Cells to the TLR3 Agonist Poly(I:C). J Immunol 174: 992–1002.
5. Trinchieri G (2010) Type I interferon: friend or foe? J Exp Med 207:
2053–2063.
6. Zhang SY, Boisson-Dupuis S, Chapgier A, Yang K, Bustamante J, et al. (2008)
Inborn errors of interferon (IFN)-mediated immunity in humans: insights into
the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host
defense. Immunol Rev 226: 29–40.
7. Sen GC, Sarkar SN (2007) The interferon-stimulated genes: targets of direct
signaling by interferons, double-stranded RNA, and viruses. Curr Top
Microbiol Immunol 316: 233–250.
8. Haller O, Staeheli P, Kochs G (2007) Interferon-induced Mx proteins in
antiviral host defense. Biochimie 89: 812–818.
9. Bisbal C, Silverman RH (2007) Diverse functions of RNase L and implications
in pathology. Biochimie 89: 789–798.
10. Hovanessian AG, Justesen J (2007) The human 29-59oligoadenylate synthetase
family: Unique interferon-inducible enzymes catalyzing 29-59 instead of 39-59
phosphodiester bond formation. Biochimie 89: 779–788.
11. Garcı ´a MA, Meurs EF, Esteban M (2007) The dsRNA protein kinase PKR:
Virus and cell control. Biochimie 89: 799–811.
12. Austin BA, James C, Silverman RH, Carr DJ (2005) Critical role for the
oligoadenylate synthetase/RNase L pathway in response to IFN-beta during
acute ocular herpes simplex virus type 1 infection. J Immunol 175: 1100–1106.
13. Bode JG, Brenndorfer ED, Haussinger D (2007) Subversion of innate host
antiviral strategies by the hepatitis C virus. Arch Biochem Biophys 462:
254–265.
14. Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, et al. (2011) A
diverse range of gene products are effectors of the type I interferon antiviral
response. Nature 472: 481–485.
15. Ghosh M, Shen Z, Fahey JV, Cu-Uvin S, Mayer K, et al. (2010) Trappin-2/
Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the
human female reproductive tract. Immunology 129: 207–219.
16. Fahey JV, Wright JA, Shen L, Smith JM, Ghosh M, et al. (2008) Estradiol
selectively regulates innate immune function by polarized human uterine
epithelial cells in culture. Mucosal Immunol 1: 317–325.
Innate Immunity in Uterine Epithelial Cells
PLoS ONE | www.plosone.org 10 April 2012 | Volume 7 | Issue 4 | e3565417. Lesmeister M, Jorgenson R, Young S, Misfeldt M (2005) 17beta-estradiol
suppresses TLR3-induced cytokine and chemokine production in endometrial
epithelial cells. Reproductive Biology and Endocrinology 3: 74.
18. Fahey JV, Schaefer TM, Channon JY, Wira CR (2005) Secretion of cytokines
and chemokines by polarized human epithelial cells from the female
reproductive tract. Human Reproduction 20: 1439–1446.
19. Mo B, Vendrov AE, Palomino WA, DuPont BR, Apparao KBC, et al. (2006)
ECC-1 Cells: A Well-Differentiated Steroid-Responsive Endometrial Cell Line
with Characteristics of Luminal Epithelium. Biology of Reproduction 75:
387–394.
20. Dogusan Z, Garcia M, Flamez D, Alexopoulou L, Goldman M, et al. (2008)
Double-stranded RNA induces pancreatic beta-cell apoptosis by activation of
the toll-like receptor 3 and interferon regulatory factor 3 pathways. Diabetes 57:
1236–1245.
21. Kim CH, Ahn JH, Kang SU, Hwang HS, Lee MH, et al. (2010) Imiquimod
induces apoptosis of human melanocytes. Arch Dermatol Res 302: 301–306.
22. Rintahaka J, Wiik D, Kovanen PE, Alenius H, Matikainen S (2008) Cytosolic
antiviral RNA recognition pathway activates caspases 1 and 3. J Immunol 180:
1749–1757.
23. Nazli A, Yao X-D, Smieja M, Rosenthal KL, Ashkar AA, et al. (2009)
Differential induction of innate anti-viral responses by TLR ligands against
Herpes simplex virus, type 2, infection in primary genital epithelium of women.
Antiviral Research 81: 103–112.
24. Novick D, Nabioullin RR, Ragsdale W, McKenna S, Weiser W, et al. (2000)
The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal
antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.
J Interferon Cytokine Res 20: 971–982.
25. Wira CR, Fahey JV, Ghosh M, Patel MV, Hickey DK, et al. (2010) Sex
Hormone Regulation of Innate Immunity in the Female Reproductive Tract:
The Role of Epithelial Cells in Balancing Reproductive Potential with Protection
against Sexually Transmitted Pathogens. American Journal of Reproductive
Immunology 63: 544–565.
26. Farnell YZ, Ing NH (2003) The effects of estradiol and selective estrogen
receptor modulators on gene expression and messenger RNA stability in
immortalized sheep endometrial stromal cells and human endometrial
adenocarcinoma cells. J Steroid Biochem Mol Biol 84: 453–461.
27. Schaefer TM, Desouza K, Fahey JV, Beagley KW, Wira CR (2004) Toll-like
receptor (TLR) expression and TLR-mediated cytokine/chemokine production
by human uterine epithelial cells. Immunology 112: 428–436.
28. Andersen JM, Al-Khairy D, Ingalls RR (2006) Innate Immunity at the Mucosal
Surface: Role of Toll-Like Receptor 3 and Toll-Like Receptor 9 in Cervical
Epithelial Cell Responses to Microbial Pathogens. Biology of Reproduction 74:
824–831.
29. Nurkkala M, Nordstro ¨m I, Telemo E, Eriksson K (2007) MHC expression and
chemokine production in the murine vagina following intra-vaginal administra-
tion of ligands to toll-like receptors 3, 7 and 9. Journal of Reproductive
Immunology 73: 148–157.
30. Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, et al. (2008) Length-
dependent recognition of double-stranded ribonucleic acids by retinoic acid-
inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med
205: 1601–1610.
31. Le Goffic R, Pothlichet J, Vitour D, Fujita T, Meurs E, et al. (2007) Cutting
Edge: Influenza A Virus Activates TLR3-Dependent Inflammatory and RIG-I-
Dependent Antiviral Responses in Human Lung Epithelial Cells. J Immunol
178: 3368–3372.
32. Nasirudeen AMA, Wong HH, Thien P, Xu S, Lam K-P, et al. (2011) RIG-I,
MDA5 and TLR3 Synergistically Play an Important Role in Restriction of
Dengue Virus Infection. PLoS Negl Trop Dis 5: e926.
33. Damdinsuren B, Nagano H, Sakon M, Kondo M, Yamamoto T, et al. (2003)
Interferon-beta is more potent than interferon-alpha in inhibition of human
hepatocellular carcinoma cell growth when used alone and in combination with
anticancer drugs. Ann Surg Oncol 10: 1184–1190.
34. Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, et al. (2005) IL-28A
and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial
cells and murine CMV infection increases colonic IL-28A expression. American
Journal of Physiology - Gastrointestinal and Liver Physiology 289: G960–G968.
35. Brand S, Zitzmann K, Dambacher J, Beigel F, Olszak T, et al. (2005) SOCS-1
inhibits expression of the antiviral proteins 29,59-OAS and MxA induced by the
novel interferon-lambdas IL-28A and IL-29. Biochem Biophys Res Commun
331: 543–548.
36. Sommereyns C, Paul S, Staeheli P, Michiels T (2008) IFN-lambda (IFN-l)i s
expressed in a tissue-dependent fashion and primarily acts on epithelial cells in
vivo. PLoS Pathog 4: e1000017.
37. Mordstein M, Neugebauer E, Ditt V, Jessen B, Rieger T, et al. (2010) Lambda
Interferon Renders Epithelial Cells of the Respiratory and Gastrointestinal
Tracts Resistant to Viral Infections. J Virol 84: 5670–5677.
38. Jacquelin B, Mayau V, Targat B, Liovat AS, Kunkel D, et al. (2009)
Nonpathogenic SIV infection of African green monkeys induces a strong but
rapidly controlled type I IFN response. J Clin Invest 119: 3544–3555.
39. Axtell RC, Raman C, Steinman L (2011) Interferon-beta exacerbates Th17-
mediated inflammatory disease. Trends Immunol 32: 272–277.
40. Pauli EK, Schmolke M, Wolff T, Viemann D, Roth J, et al. (2008) Influenza A
virus inhibits type I IFN signaling via NF-kappaB-dependent induction of
SOCS-3 expression. PLoS Pathog 4: e1000196.
41. Piganis RA, de Weerd NA, Gould JA, Schindler CW, Mansell A, et al. (2011)
Suppressor of cytokine signaling (SOCS)1 inhibits type I interferon (IFN)
signaling via the IFNAR1 associated tyrosine kinase, Tyk2. J Biol Chem.
42. Vlotides G, So ¨rensen AS, Kopp F, Zitzmann K, Cengic N, et al. (2004) SOCS-1
and SOCS-3 inhibit IFN-[alpha]-induced expression of the antiviral proteins
2,5-OAS and MxA. Biochemical and Biophysical Research Communications
320: 1007–1014.
43. Murphy JA, Duerst RJ, Smith TJ, Morrison LA (2003) Herpes simplex virus
type 2 virion host shutoff protein regulates alpha/beta interferon but not
adaptive immune responses during primary infection in vivo. Journal of Virology
77: 9337–9345.
44. Trapp S, Derby NR, Singer R, Shaw A, Williams VG, et al. (2009) Double-
Stranded RNA Analog Poly(I:C) Inhibits Human Immunodeficiency Virus
Amplification in Dendritic Cells via Type I Interferon-Mediated Activation of
APOBEC3G. Journal of Virology 83: 884–895.
45. Conrady CD, Halford WP, Carr DJ (2011) Loss of the type I interferon pathway
increases vulnerability of mice to genital herpes simplex virus 2 infection. Journal
of Virology 85: 1625–1633.
46. Pitha PM (1994) Multiple effects of interferon on the replication of human
immunodeficiency virus type 1. Antiviral Research 24: 205–219.
47. Adelson ME, Martinand-Mari C, Iacono KT, Muto NF, Suhadolnik RJ (1999)
Inhibition of human immunodeficiency virus (HIV-1) replication in SupT1 cells
transduced with an HIV-1 LTR-driven PKR cDNA construct. European
Journal of Biochemistry 264: 806–815.
48. Maitra RK, Silverman RH (1998) Regulation of Human Immunodeficiency
Virus Replication by 29,59-Oligoadenylate-Dependent RNase L. Journal of
Virology 72: 1146–1152.
49. Watts JM, Dang KK, Gorelick RJ, Leonard CW, Bess JW, Jr., et al. (2009)
Architecture and secondary structure of an entire HIV-1 RNA genome. Nature
460: 711–716.
50. Yao X-D, Rosenthal KL (2011) Herpes simplex virus type 2 virion host shutoff
protein suppresses innate dsRNA antiviral pathways in human vaginal epithelial
cells. Journal of General Virology 92: 1981–1993.
51. Akhtar LN, Qin H, Muldowney MT, Yanagisawa LL, Kutsch O, et al. (2010)
Suppressor of Cytokine Signaling 3 Inhibits Antiviral IFN-b Signaling To
Enhance HIV-1 Replication in Macrophages. J Immunol 185: 2393–2404.
52. Martinand C, Montavon C, Salehzada T, Silhol M, Lebleu B, et al. (1999)
RNase L inhibitor is induced during human immunodeficiency virus type 1
infection and down regulates the 2-5A/RNase L pathway in human T cells.
Journal of Virology 73: 290–296.
53. Clerzius G, Gelinas JF, Daher A, Bonnet M, Meurs EF, et al. (2009) ADAR1
interacts with PKR during human immunodeficiency virus infection of
lymphocytes and contributes to viral replication. Journal of Virology 83:
10119–10128.
54. Ku C-C, Che X-B, Reichelt M, Rajamani J, Schaap-Nutt A, et al. (2011) Herpes
simplex virus-1 induces expression of a novel MxA isoform that enhances viral
replication. Immunol Cell Biol 89: 173–182.
55. Pentecost BT (1998) Expression and estrogen regulation of the HEM45 mRNA
in human tumor lines and in the rat uterus. The Journal of Steroid Biochemistry
and Molecular Biology 64: 25–33.
56. Fahey JV, Wira CR (2002) Effect of Menstrual Status on Antibacterial Activity
and Secretory Leukocyte Protease Inhibitor Production by Human Uterine
Epithelial Cells in Culture. The Journal of Infectious Diseases 185: 1606–1613.
57. Escribese MM, Kraus T, Rhee E, Fernandez-Sesma A, Lo ´pez CB, et al. (2008)
Estrogen inhibits dendritic cell maturation to RNA viruses. Blood 112:
4574–4584.
58. Nazli A, Chan O, Dobson-Belaire WN, Ouellet M, Tremblay MJ, et al. (2010)
Exposure to HIV-1 Directly Impairs Mucosal Epithelial Barrier Integrity
Allowing Microbial Translocation. PLoS Pathog 6: e1000852.
Innate Immunity in Uterine Epithelial Cells
PLoS ONE | www.plosone.org 11 April 2012 | Volume 7 | Issue 4 | e35654